Meeting NewsVideo

VIDEO: Pearls on surgical considerations prior to IOL exchange

July 13, 2019
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Neel R. Desai, MD, discusses considerations when planning IOL exchange as well as…

Orion system shows positive safety, efficacy profile in feasibility study

July 12, 2019
An early feasibility study showed the Orion visual cortical prosthesis system was generally safe, with all patients being able to see phosphenes and…

Dosing underway in BioTime dry AMD trial

July 12, 2019
The first patient has been dosed in an ongoing phase 1/2a clinical trial with a new thaw-and-inject formulation of OpRegen, delivered with the Orbit…

Meeting NewsVideo

VIDEO: US launch of Rocklatan and other updates from Aerie

July 9, 2019
NEWPORT BEACH, Calif. — At OCTANe’s Ophthalmology Technology Summit, Tom Mitro, president and chief operating officer of Aerie…

AOA issues advisories on diabetes, STDs

July 9, 2019
The American Optometric Association is asking for public comment on its updated practice guideline on diabetes mellitus and has also issued a brief…

Clarus 700 receives FDA clearance

July 9, 2019
The FDA has issued 510(k) clearance to Zeiss’s Clarus 700 ultra-widefield imaging system, the company announced in a press release. Clarus 700…

In the Journals

Microvascular disease elevates risk for amputation

July 8, 2019
Regardless of where it resided in the body and whether it was concomitant with peripheral artery disease, microvascular disease was associated with…

Meeting NewsVideo

VIDEO: OCT a game-changer for optometric practice

July 3, 2019
ST. LOUIS – Jim Fanelli, OD, FAAO, said here at Optometry’s Meeting that he uses OCT in his practice for patients who have macular…

Do not use sterile products from AmEx Pharmacy, FDA warns

July 3, 2019
The FDA is warning against the use of products intended to be sterile from Pacifico National Inc., which does business as AmEx Pharmacy, according to…


New drug application for Brilliant Blue G solution accepted

July 2, 2019
The FDA has accepted an orphan new drug application for Brilliant Blue G ophthalmic solution for staining the internal limiting membrane, Dutch…

Positive topline results reported for Oxurion’s DME treatment

July 1, 2019
Oxurion’s plasma kallikrein inhibitor treatment candidate for diabetic macular edema was safe and well-tolerated in a phase 1 study. A single…

Meeting NewsVideo

VIDEO: Two Blind Brothers share their mission to cure inherited retinal disease

July 1, 2019
NEWPORT BEACH, Calif. — At OCTANe’s Ophthalmology Technology Summit, Jason Menzo, of Foundation Fighting Blindness, interviews…

In the JournalsPerspective

Silicone oil in syringes contributes to cluster of inflammatory reactions

June 28, 2019
A cluster of post-intravitreal injection inflammatory reaction cases was associated in a study with silicone oil droplets released by Saldanha…

Meeting NewsVideo

VIDEO: Pre-exam wide-field photos add to office efficiency

June 28, 2019
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting here, Alan Kozarsky, MD, discusses the use of wide-field fundus imaging and the benefits…

FDA approves Alexion’s treatment for neuromyelitis optica spectrum disorder

June 27, 2019
The FDA has announced approval of Soliris injection for treatment of neuromyelitis optica spectrum disorder in adult patients who are…

In the Journals

Stroke type unrelated to anti-VEGF treatment

June 26, 2019
Type of stroke suffered, whether ischemic or hemorrhagic, in patients with retinal disease was not influenced by anti-VEGF treatment, according to a…

Aldeyra to stop noninfectious anterior uveitis program

June 25, 2019
Aldeyra intends to discontinue its noninfectious anterior uveitis program after no primary or secondary endpoints were achieved in the SOLACE trial. …

Central serous chorioretinopathy patient treated with Lutronic’s R:GEN laser in Korea

June 19, 2019
Lutronic Vision’s R:GEN retina treatment laser has been used to treat the first patient with central serous chorioretinopathy at Seoul National…

Retinitis pigmentosa stem cell study tops ARVO news

June 18, 2019
The annual Association for Research in Vision and Ophthalmology meeting was held in Vancouver, British Columbia, from April 28 to May 2. Here are…

Ribomic's wet AMD candidate shows positive phase 1/2a topline results

June 18, 2019
A single dose of RBM-007, an oligonucleotide-based aptamer with anti-FGF2 activity, showed positive topline results in a phase 1/2a clinical trial in…